Related Experiment Video
Updated: Mar 31, 2026

08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
10.1K
Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: A two-year longitudinal study
Md Nasir Uddin1, R Marc Lebel1, Peter Seres1
1Department of Biomedical Engineering, University of Alberta, Canada.
Summary
Deep gray matter changes in relapsing-remitting multiple sclerosis (RRMS) patients over two years correlate with disease severity. Magnetic resonance imaging (MRI) R2 mapping and atrophy measurements can track these DGM changes in MS.
Area of Science:
- Neuroimaging
- Radiology
- Neurology
Background:
- Deep gray matter (DGM) is impacted in relapsing-remitting multiple sclerosis (RRMS).
- Short-term longitudinal magnetic resonance imaging (MRI) is a potential tool for studying DGM in RRMS.
- Understanding DGM changes is crucial for managing MS progression.
Purpose of the Study:
- To assess two-year changes in spin-echo transverse relaxation rate (R2) and atrophy in the DGM of RRMS patients.
- To investigate the relationship between these DGM changes and disease severity in RRMS.
- To evaluate the utility of R2 mapping and atrophy measurements for monitoring MS.
Main Methods:
- Twenty-six RRMS patients and 26 matched controls underwent 4.7 T MRI.
- Multiecho spin-echo R2 maps and atrophy measurements were acquired at baseline and two-year follow-up.
- Statistical analyses examined differences in MRI measures and correlations with disease severity.
Main Results:
- Mean R2 values in the globus pallidus and pulvinar increased significantly (~4%) in RRMS patients over two years compared to controls.
- Two-year R2 changes in the globus pallidus, pulvinar, substantia nigra, and thalamus correlated significantly with disease severity.
- Multiple regression analysis showed a strong correlation (r=0.83, p<0.001) between DGM R2 changes and disease severity.
Conclusions:
- Two-year R2 measurements in DGM show a significant correlation with disease severity in multiple sclerosis (MS).
- R2 mapping and atrophy measurements over two years are effective in identifying DGM changes in MS patients.
- Longitudinal MRI techniques can provide valuable insights into neurodegeneration in MS.

